Genasense: Phase II

Among the first 13 patients with advanced, hormone-refractory prostate cancer in GNTA's

Read the full 124 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE